预测急性重症溃疡性结肠炎住院后1年内结肠切除风险的评分系统
本研究基于法国两家医院2002至2017年270例急性重症溃疡性结肠炎(ASUC)患者的数据,通过Cox多因素分析识别出4个独立危险因素并构建评分系统,用于预测住院后1年内结肠切除风险。衍生队列中,评分0、1、2、3、4分对应的1年累积结肠切除风险分别为0.0%、9.4%、10.6%、51.2%和100%,阴性预测值87%至92%。该评分系统在185例独立验证队列中结果一致。
要点
- 评分基于既往使用TNF拮抗剂或硫嘌呤、艰难梭菌感染、CRP>30 mg/L和 albumin<30 g/L四项,每项1分。
- 评分3或4分为高风险,0分为低风险,1-2分为中等风险。
- 低评分患者1年结肠切除风险极低,阴性预测值87%-92%。
核心结论
- 基于既往使用TNF拮抗剂或硫嘌呤、艰难梭菌感染、CRP>30 mg/L和albumin<30 g/L四项指标构建的评分系统,可区分ASUC患者住院后1年内结肠切除的低风险与高风险。
研究设计与样本
- 回顾性分析法国2家医院2002至2017年连续收治的270例ASUC患者(衍生队列),中位随访30个月。
- 使用Cox多因素分析识别独立危险因素并构建评分系统(每项1分),在高风险(3或4分)与低风险(0分)患者中验证。
- 在法国2个中心2006至2017年治疗的185例ASUC独立队列中验证该评分系统。
主要发现
- 衍生队列1年累积结肠切除风险为12.3%(95%CI 8.6-16.8)。
- 多因素分析显示,既往使用TNF拮抗剂或硫嘌呤(HR 3.86;95%CI 1.82-8.18)、艰难梭菌感染(HR 3.73;95%CI 1.11-12.55)、CRP>30 mg/L(HR 3.06;95%CI 1.11-8.43)、albumin<30 g/L(HR 2.67;95%CI 1.20-5.92)与结肠切除风险增加相关。
- 衍生队列中,评分0、1、2、3、4分对应的1年累积结肠切除风险分别为0.0%、9.4%(95%CI 4.3%-16.7%)、10.6%(95%CI 5.6%-17.4%)、51.2%(95%CI 26.6%-71.3%)和100%。
- 阴性预测值范围为87%(95%CI 82%-91%)至92%(95%CI 88%-95.0%)。
- 验证队列结果与衍生队列一致。
关键数值与推荐
- 评分项目:既往使用TNF拮抗剂或硫嘌呤(1分)、艰难梭菌感染(1分)、CRP>30 mg/L(1分)、albumin<30 g/L(1分)。
- 高风险定义为评分3或4分,低风险定义为评分0分。
临床怎么用
- 对ASUC住院患者,入院时可依据既往TNF拮抗剂或硫嘌呤使用史、艰难梭菌感染、CRP和albumin水平计算评分,识别1年内结肠切除高风险患者。
- 评分0分的患者1年结肠切除风险极低,或可支持更保守的管理策略;评分3或4分提示高风险,需加强监测和治疗决策。
局限性
- 回顾性研究设计。
- 衍生队列和验证队列均来自法国,外推性需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: There is consensus on the criteria used to define acute severe ulcerative colitis (ASUC) and on patient management, but it has been a challenge to identify patients at risk for colectomy based on data collected at hospital admission. We aimed to develop a system to determine patients' risk of colectomy within 1 y of hospital admission for ASUC based on clinical, biomarker, and endoscopy data. METHODS: We performed a retrospective analysis of consecutive patients with ASUC treated with corticosteroids, ciclosporin, or tumor necrosis factor (TNF) antagonists and admitted to 2 hospitals in France from 2002 through 2017. Patients were followed until colectomy or loss of follow up. A total of 270 patients with ASUC were included in the final analysis, with a median follow-up time of 30 months (derivation cohort). Independent risk factors identified by Cox multivariate analysis were used to develop a system to identify patients at risk for colectomy 1 y after ASUC. We developed a scoring system based on these 4 factors (1 point for each item) to identify high-risk (score 3 or 4) vs low-risk (score 0) patients. We validated this system using data from an independent cohort of 185 patients with ASUC treated from 2006 through 2017 at 2 centers in France. RESULTS: In the derivation cohort, the cumulative risk of colectomy was 12.3% (95% CI, 8.6-16.8). Based on multivariate analysis, previous treatment with TNF antagonists or thiopurines (hazard ratio [HR], 3.86; 95% CI, 1.82-8.18), Clostridioides difficile infection (HR, 3.73; 95% CI, 1.11-12.55), serum level of C-reactive protein above 30 mg/L (HR, 3.06; 95% CI, 1.11-8.43), and serum level of albumin below 30 g/L (HR, 2.67; 95% CI, 1.20-5.92) were associated with increased risk of colectomy. In the derivation cohort, the cumulative risks of colectomy within 1 y in patients with scores of 0, 1, 2, 3, or 4 were 0.0%, 9.4% (95% CI, 4.3%-16.7%), 10.6% (95% CI, 5.6%-17.4%), 51.2% (95% CI, 26.6%-71.3%), and 100%. Negative predictive values ranged from 87% (95% CI, 82%-91%) to 92% (95% CI, 88%-95.0%). Findings from the validation cohort were consistent with findings from the derivation cohort. CONCLUSIONS: We developed a scoring system to identify patients at low-risk vs high-risk for colectomy within 1 y of hospitalization for ASUC, based on previous treatment with TNF antagonists or thiopurines, C difficile infection, and serum levels of CRP and albumin. The system was validated in an external cohort.
引用
- Le Baut G, Kirchgesner J, Amiot A, et al. A Scoring System to Determine Patients' Risk of Colectomy Within 1 Year After Hospital Admission for Acute Severe Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020. PMID: 31927106. doi:10.1016/j.cgh.2019.12.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。